<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31779252</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>23</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>26</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Lipidomic Profiling Reveals Significant Perturbations of Intracellular Lipid Homeostasis in Enterovirus-Infected Cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5952</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms20235952</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) and coxsackievirus A16 (CV-A16) are the most common causes of hand, foot, and mouth disease. Severe EV-A71 and CV-A16 infections may be associated with life-threatening complications. However, the pathogenic mechanisms underlying these severe clinical and pathological features remain incompletely understood. Lipids are known to play critical roles in multiple stages of the virus replication cycle. The specific lipid profile induced upon virus infection is required for optimal virus replication. The perturbations in the host cell lipidomic profiles upon enterovirus infection have not been fully characterized. To this end, we performed ultra-high performance liquid chromatography-electrospray ionization-quadrupole-time of flight-mass spectrometry (UPLC-ESI-Q-TOF-MS)-based lipidomics to characterize the change in host lipidome upon EV-A71 and CV-A16 infections. Our results revealed that 47 lipids within 11 lipid classes were significantly perturbed after EV-A71 and CV-A16 infection. Four polyunsaturated fatty acids (PUFAs), namely, arachidonic acid (AA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA), and eicosapentaenoic acid (EPA), were consistently upregulated upon EV-A71 and CV-A16 infection. Importantly, exogenously supplying three of these four PUFAs, including AA, DHA, and EPA, in cell cultures significantly reduced EV-A71 and CV-A16 replication. Taken together, our results suggested that enteroviruses might specifically modulate the host lipid pathways for optimal virus replication. Excessive exogenous addition of lipids that disrupted this delicate homeostatic state could prevent efficient viral replication. Precise manipulation of the host lipid profile might be a potential host-targeting antiviral strategy for enterovirus infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Bingpeng</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Zijiao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Hin</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2855-9837</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2657-5342</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsang</LastName><ForeName>Jessica Oi-Ling</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Pok-Man</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Shuofeng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yip</LastName><ForeName>Cyril Chik-Yan</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Feifei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, Hainan Medical University, Haikou 571101, China &amp; The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathogen Biology, Hainan Medical University, Haikou, Hainan 571101, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Translational Tropical Medicine, Hainan Medical University, Haikou 571101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Richard Yi-Tsun</ForeName><Initials>RY</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sze</LastName><ForeName>Kong-Hung</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Susanna Kar-Pui</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Jasper Fuk-Woo</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0001-6336-6657</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, Hainan Medical University, Haikou 571101, China &amp; The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuen</LastName><ForeName>Kwok-Yung</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, Hainan Medical University, Haikou 571101, China &amp; The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HKM-15-M02</GrantID><Agency>Food and Health Bureau, Hong Kong Special Administrative Region Government</Agency><Country/></Grant><Grant><GrantID>HKM-15-M04</GrantID><Agency>Food and Health Bureau, Hong Kong Special Administrative Region Government</Agency><Country/></Grant><Grant><GrantID>HKM-15-M05</GrantID><Agency>Food and Health Bureau, Hong Kong Special Administrative Region Government</Agency><Country/></Grant><Grant><GrantID>HKM-15-M11</GrantID><Agency>Food and Health Bureau, Hong Kong Special Administrative Region Government</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081362" MajorTopicYN="N">Lipidomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021241" MajorTopicYN="N">Spectrometry, Mass, Electrospray Ionization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">UPLC-ESI-Q-TOF-MS</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">fatty acid</Keyword><Keyword MajorTopicYN="N">lipidomics</Keyword></KeywordList><CoiStatement>J.F.-W.C. has received travel grants from Pfizer Corporation Hong Kong and Astellas Pharma Hong Kong Corporation Limited, and was an invited speaker for Gilead Sciences Hong Kong Limited and Luminex Corporation. The other authors declared no conflict of interests. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31779252</ArticleId><ArticleId IdType="pmc">PMC6928875</ArticleId><ArticleId IdType="doi">10.3390/ijms20235952</ArticleId><ArticleId IdType="pii">ijms20235952</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong S.S., Yip C.C., Lau S.K., Yuen K.Y. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect. 2010;138:1071&#x2013;1089. doi: 10.1017/S0950268809991555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268809991555</ArticleId><ArticleId IdType="pubmed">20056019</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., Liao Q., Viboud C., Zhang J., Sun J., Wu J.T., Chang Z., Liu F., Fang V.J., Zheng Y., et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect. Dis. 2014;14:308&#x2013;318. doi: 10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.Y., Lin T.Y., Hsu K.H., Huang Y.C., Lin K.L., Hsueh C., Shih S.R., Ning H.C., Hwang M.S., Wang H.S., et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354:1682&#x2013;1686. doi: 10.1016/S0140-6736(99)04434-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)04434-7</ArticleId><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip C.C., Lau S.K., Woo P.C., Yuen K.Y. Human enterovirus 71 epidemics: what&#x2019;s next? Emerg Health Threats J. 2013;6:19780. doi: 10.3402/ehtj.v6i0.19780.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/ehtj.v6i0.19780</ArticleId><ArticleId IdType="pmc">PMC3772321</ArticleId><ArticleId IdType="pubmed">24119538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Taube S., Jiang M.X., Wobus C.E. Glycosphingolipids as Receptors for Non-Enveloped Viruses. Viruses-Basel. 2010;2:1011&#x2013;1049. doi: 10.3390/v2041011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v2041011</ArticleId><ArticleId IdType="pmc">PMC3185660</ArticleId><ArticleId IdType="pubmed">21994669</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazal N., Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiol Mol. Biol Rev. 2003;67:226&#x2013;237. doi: 10.1128/MMBR.67.2.226-237.2003. table of contents.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.67.2.226-237.2003</ArticleId><ArticleId IdType="pmc">PMC156468</ArticleId><ArticleId IdType="pubmed">12794191</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy P.D., Strating J.R.P.M., van Kuppeveld F.J.M. Building Viral Replication Organelles: Close Encounters of the Membrane Types. Plos Pathogens. 2016;12 doi: 10.1371/journal.ppat.1005912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005912</ArticleId><ArticleId IdType="pmc">PMC5082816</ArticleId><ArticleId IdType="pubmed">27788266</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu N.Y., Ilnytska O., Belov G., Santiana M., Chen Y.H., Takvorian P.M., Pau C., van der Schaar H., Kaushik-Basu N., Balla T., et al. Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication. Cell. 2010;141:799&#x2013;811. doi: 10.1016/j.cell.2010.03.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.03.050</ArticleId><ArticleId IdType="pmc">PMC2982146</ArticleId><ArticleId IdType="pubmed">20510927</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono A., Ablan S.D., Lockett S.J., Nagashima K., Freed E.O. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl Acad Sci USA. 2004;101:14889&#x2013;14894. doi: 10.1073/pnas.0405596101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0405596101</ArticleId><ArticleId IdType="pmc">PMC522033</ArticleId><ArticleId IdType="pubmed">15465916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Pekosz A., Lamb R.A. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J. Virol. 2000;74:4634&#x2013;4644. doi: 10.1128/JVI.74.10.4634-4644.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.10.4634-4644.2000</ArticleId><ArticleId IdType="pmc">PMC111983</ArticleId><ArticleId IdType="pubmed">10775599</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller C., Hardt M., Schwudke D., Neuman B.W., Pleschka S., Ziebuhr J. Inhibition of Cytosolic Phospholipase A2alpha Impairs an Early Step of Coronavirus Replication in Cell Culture. J. Virol. 2018;92 doi: 10.1128/JVI.01463-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01463-17</ArticleId><ArticleId IdType="pmc">PMC5790932</ArticleId><ArticleId IdType="pubmed">29167338</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B., Chu H., Yang D., Sze K.H., Lai P.M., Yuan S., Shuai H., Wang Y., Kao R.Y., Chan J.F., et al. Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication. Viruses. 2019;11 doi: 10.3390/v11010073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11010073</ArticleId><ArticleId IdType="pmc">PMC6357182</ArticleId><ArticleId IdType="pubmed">30654597</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauling J.K., Hermansson M., Hartler J., Christiansen K., Gallego S.F., Peng B., Ahrends R., Ejsing C.S. Proposal for a common nomenclature for fragment ions in mass spectra of lipids. PLoS ONE. 2017;12:e0188394. doi: 10.1371/journal.pone.0188394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0188394</ArticleId><ArticleId IdType="pmc">PMC5697860</ArticleId><ArticleId IdType="pubmed">29161304</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B., Deng Y., Hou J., Bi Q., Yang M., Jiang B., Liu X., Wu W., Guo D. UHPLC-LTQ-Orbitrap MS combined with spike-in method for plasma metabonomics analysis of acute myocardial ischemia rats and pretreatment effect of Danqi Tongmai tablet. Mol. Biosyst. 2015;11:486&#x2013;496. doi: 10.1039/C4MB00529E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4MB00529E</ArticleId><ArticleId IdType="pubmed">25418780</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsugawa H., Cajka T., Kind T., Ma Y., Higgins B., Ikeda K., Kanazawa M., VanderGheynst J., Fiehn O., Arita M. MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat. Methods. 2015;12:523&#x2013;526. doi: 10.1038/nmeth.3393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3393</ArticleId><ArticleId IdType="pmc">PMC4449330</ArticleId><ArticleId IdType="pubmed">25938372</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahy E., Cotter D., Sud M., Subramaniam S. Lipid classification, structures and tools. Biochim Biophys Acta. 2011;1811:637&#x2013;647. doi: 10.1016/j.bbalip.2011.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2011.06.009</ArticleId><ArticleId IdType="pmc">PMC3995129</ArticleId><ArticleId IdType="pubmed">21704189</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebisch G., Vizcaino J.A., Kofeler H., Trotzmuller M., Griffiths W.J., Schmitz G., Spener F., Wakelam M.J. Shorthand notation for lipid structures derived from mass spectrometry. J. Lipid Res. 2013;54:1523&#x2013;1530. doi: 10.1194/jlr.M033506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M033506</ArticleId><ArticleId IdType="pmc">PMC3646453</ArticleId><ArticleId IdType="pubmed">23549332</ArticleId></ArticleIdList></Reference><Reference><Citation>Thormar H., Isaacs C.E., Brown H.R., Barshatzky M.R., Pessolano T. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother. 1987;31:27&#x2013;31. doi: 10.1128/AAC.31.1.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.31.1.27</ArticleId><ArticleId IdType="pmc">PMC174645</ArticleId><ArticleId IdType="pubmed">3032090</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., Chen Y.J., Wu K., Yan H., Hao X.A., Wu Y.F. Application of fatty acids as antiviral agents against tobacco mosaic virus. Pesticide Biochemistry and Physiology. 2017;139:87&#x2013;91. doi: 10.1016/j.pestbp.2017.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pestbp.2017.05.005</ArticleId><ArticleId IdType="pubmed">28595927</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienz K., Egger D., Pfister T., Troxler M. Structural and functional characterization of the poliovirus replication complex. J. Virol. 1992;66:2740&#x2013;2747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC241029</ArticleId><ArticleId IdType="pubmed">1313898</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlegel A., Giddings T.H., Jr., Ladinsky M.S., Kirkegaard K. Cellular origin and ultrastructure of membranes induced during poliovirus infection. J. Virol. 1996;70:6576&#x2013;6588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190698</ArticleId><ArticleId IdType="pubmed">8794292</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhy D.A., Giddings T.H., Jr., Kirkegaard K. Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J. Virol. 2000;74:8953&#x2013;8965. doi: 10.1128/JVI.74.19.8953-8965.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.19.8953-8965.2000</ArticleId><ArticleId IdType="pmc">PMC102091</ArticleId><ArticleId IdType="pubmed">10982339</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen A., Guedan A., Mousnier A., Swieboda D., Zhang Q., Horkai D., Le Novere N., Solari R., Wakelam M.J.O. Host lipidome analysis during rhinovirus replication in HBECs identifies potential therapeutic targets. J. Lipid Res. 2018;59:1671&#x2013;1684. doi: 10.1194/jlr.M085910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M085910</ArticleId><ArticleId IdType="pmc">PMC6121942</ArticleId><ArticleId IdType="pubmed">29946055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratnayake W.M., Galli C. Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper. Ann. Nutr. Metab. 2009;55:8&#x2013;43. doi: 10.1159/000228994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000228994</ArticleId><ArticleId IdType="pubmed">19752534</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita M., Kuba K., Ichikawa A., Nakayama M., Katahira J., Iwamoto R., Watanebe T., Sakabe S., Daidoji T., Nakamura S., et al. The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza. Cell. 2013;153:112&#x2013;125. doi: 10.1016/j.cell.2013.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.02.027</ArticleId><ArticleId IdType="pubmed">23477864</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz G., Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res. 2008;47:147&#x2013;155. doi: 10.1016/j.plipres.2007.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2007.12.004</ArticleId><ArticleId IdType="pubmed">18198131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.Y., Plakidas A., Lee W.H., Heikkinen A., Chanmugam P., Bray G., Hwang D.H. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 2003;44:479&#x2013;486. doi: 10.1194/jlr.M200361-JLR200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M200361-JLR200</ArticleId><ArticleId IdType="pubmed">12562875</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim A., Mbodji K., Hassan A., Aziz M., Boukhettala N., Coeffier M., Savoye G., Dechelotte P., Marion-Letellier R. Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium. Clin. Nutr. 2011;30:678&#x2013;687. doi: 10.1016/j.clnu.2011.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2011.05.002</ArticleId><ArticleId IdType="pubmed">21632157</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Yoshida M., Hong S., Tjonahen E., Glickman J.N., Petasis N.A., Blumberg R.S., Serhan C.N. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl Acad Sci USA. 2005;102:7671&#x2013;7676. doi: 10.1073/pnas.0409271102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0409271102</ArticleId><ArticleId IdType="pmc">PMC1103706</ArticleId><ArticleId IdType="pubmed">15890784</ArticleId></ArticleIdList></Reference><Reference><Citation>Marion-Letellier R., Savoye G., Ghosh S. Polyunsaturated fatty acids and inflammation. IUBMB Life. 2015;67:659&#x2013;667. doi: 10.1002/iub.1428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1428</ArticleId><ArticleId IdType="pubmed">26397837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann S., Krajewski M., Scherer C., Scholz V., Mordhorst V., Truschow P., Schobel A., Reimer R., Schwudke D., Herker E. Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids. 2018;1863:1041&#x2013;1056. doi: 10.1016/j.bbalip.2018.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2018.06.002</ArticleId><ArticleId IdType="pubmed">29885363</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S., Chu H., Chan J.F., Ye Z.W., Wen L., Yan B., Lai P.M., Tee K.M., Huang J., Chen D., et al. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Nat. Commun. 2019;10:120. doi: 10.1038/s41467-018-08015-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-08015-x</ArticleId><ArticleId IdType="pmc">PMC6328544</ArticleId><ArticleId IdType="pubmed">30631056</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnum-Johnson K.E., Kyle J.E., Eisfeld A.J., Casey C.P., Stratton K.G., Gonzalez J.F., Habyarimana F., Negretti N.M., Sims A.C., Chauhan S., et al. MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling. Analyst. 2017;142:442&#x2013;448. doi: 10.1039/C6AN02486F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6AN02486F</ArticleId><ArticleId IdType="pmc">PMC5283721</ArticleId><ArticleId IdType="pubmed">28091625</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva L.P., Lorenzi P.L., Purwaha P., Yong V., Hawke D.H., Weinstein J.N., editors. Measurement of DNA concentration as a normalization strategy for metabolomic data from adherent cell lines. 2013;Volume 85:9536&#x2013;9542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3868625</ArticleId><ArticleId IdType="pubmed">24011029</ArticleId></ArticleIdList></Reference><Reference><Citation>Damen C.W., Isaac G., Langridge J., Hankemeier T., Vreeken R.J. Enhanced lipid isomer separation in human plasma using reversed-phase UPLC with ion-mobility/high-resolution MS detection. J. Lipid Res. 2014;55:1772&#x2013;1783. doi: 10.1194/jlr.D047795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.D047795</ArticleId><ArticleId IdType="pmc">PMC4109771</ArticleId><ArticleId IdType="pubmed">24891331</ArticleId></ArticleIdList></Reference><Reference><Citation>Cajka T., Fiehn O. Increasing lipidomic coverage by selecting optimal mobile-phase modifiers in LC&#x2013;MS of blood plasma. Metabolomics. 2016;12 doi: 10.1007/s11306-015-0929-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-015-0929-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn W.B., Broadhurst D., Begley P., Zelena E., Francis-McIntyre S., Anderson N., Brown M., Knowles J.D., Halsall A., Haselden J.N., et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 2011;6:1060&#x2013;1083. doi: 10.1038/nprot.2011.335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2011.335</ArticleId><ArticleId IdType="pubmed">21720319</ArticleId></ArticleIdList></Reference><Reference><Citation>Kind T., Liu K.H., Lee D.Y., DeFelice B., Meissen J.K., Fiehn O. LipidBlast in silico tandem mass spectrometry database for lipid identification. Nat. Methods. 2013;10:755&#x2013;758. doi: 10.1038/nmeth.2551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2551</ArticleId><ArticleId IdType="pmc">PMC3731409</ArticleId><ArticleId IdType="pubmed">23817071</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J., Sinelnikov I.V., Han B., Wishart D.S. MetaboAnalyst 3.0--making metabolomics more meaningful. Nucleic Acids Res. 2015;43:W251&#x2013;W257. doi: 10.1093/nar/gkv380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv380</ArticleId><ArticleId IdType="pmc">PMC4489235</ArticleId><ArticleId IdType="pubmed">25897128</ArticleId></ArticleIdList></Reference><Reference><Citation>Galindo-Prieto B., Eriksson L., Trygg J. Variable influence on projection (VIP) for orthogonal projections to latent structures (OPLS) J. Chem. 2014;28:623&#x2013;632. doi: 10.1002/cem.2627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cem.2627</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>